> On the heels of yesterday's announcement of Amgen and Abgenix's successful colorectal study, both companies stock prices soared while rival ImClone enjoyed less success. Article [1]
> Cytori Therapeutics and Olympus announced that they will collaborate to develop and manufacture systems for stem and regenerative cell therapies. Release [2]
> GSK is planning to invest $115 million in a new laboratory facility in Singapore. The purpose of the site will be to convert experimental molecules into medicines in order to bolster GSK's internal pipeline. Release [3]
> UK biotech Biopure as received approval to begin phase 2 trials for experimental oxygen therapeutic Hemopure, a therapy for patients healing from lower limb amputation. Report [4]
And Finally... Researchers say that combining aspirin with the drug clopidogrel (Sanofi-Aventis' Plavix) could prevent thousands of deaths. Report [5]
Links:
[1] http://www.latimes.com/business/printedition/la-fi-amgen4nov04,1,3724425.story?coll=la-headlines-pe-business
[2] http://www.biotech-intelligence.com/html/html/4ca71a17d3abbf96018b273bda2804f7.html
[3] http://www.biotech-intelligence.com/html/html/06254cce8525a47a2ca2d60c72d47c1c.html
[4] http://www.datamonitor.com/~f8235e80d842478cb3ad2459a6292a05~/industries/news/article/?pid=AED03860-9C87-45F0-9CA4-D691F7DD3DD5&type=NewsWire
[5] http://news.yahoo.com/s/hsn/20051104/hl_hsn/plavixhelpsheartattackpatientssurvive